In this study we moved from the hypothesis that at least a subgroup of patients with schizophrenia spectrum psychosis may have a specific vulnerability for abnormalities of regulation of PRL secretion and impaired glucose tolerance, independent of antipsychotic treatment. The gene discussed is PRL; the disease is psychotic disorder.